• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

姜黄素磷脂复合物与 Soluplus 固化的研究。

Studies on the curcumin phospholipid complex solidified with Soluplus.

机构信息

Department of Pharmacy, Jining Medical University, Shandong, China.

Hospital of Integrated Traditional Chinese and Western Medicine Affiliated to Nanjing University of Chinese Medicine, Nanjing, China.

出版信息

J Pharm Pharmacol. 2018 Feb;70(2):242-249. doi: 10.1111/jphp.12857. Epub 2017 Nov 17.

DOI:10.1111/jphp.12857
PMID:29148063
Abstract

OBJECTIVES

With the purpose of developing a curcumin phospholipid complex (CPC) formulation with high performance, the CPC was prepared and solidified with Soluplus in this study.

METHODS

Soluplus was used as a carrier to solidify CPC. The structures of the CPC and curcumin phospholipid complex - Soluplus solidified powder (CSP) - were also characterized by differential scanning electron microscope, differential scanning calorimetry, Fourier transform infrared spectroscopy and X-ray diffractometer, and flowability, in-vitro dissolution and oral bioavailability were also investigated.

KEY FINDINGS

All analysis indicated that curcumin was completely converted from crystalline to amorphous state in solidified powder. The angle of repose calculated in flowability study indicated a marked improvement from 'cannot be measured' to '37°'. Meanwhile, the dissolution study showed that in phosphate buffer condition, the dissolution rate of CSP had released 76.34% in pH 6.8 and the 78.19% in pH 1.2. Furthermore, in pharmacokinetic study, significant (P < 0.01) improvement of AUC value was observed between CPC and CSP groups, and the results showed that AUC value was increased from 205.84 ± 50.46 μg h/ml to 330.47 μg h/ml.

CONCLUSIONS

A simple and convenient solidifying process was used in this study, and the data suggested that this process not only could improve the flowability and dissolution of phospholipid complex, but also increased the oral bioavailability of curcumin.

摘要

目的

为了开发一种性能优良的姜黄素磷脂复合物(CPC)制剂,本研究采用 Soluplus 对 CPC 进行固化。

方法

采用 Soluplus 作为载体对 CPC 进行固化。采用差示扫描电子显微镜、差示扫描量热法、傅里叶变换红外光谱和 X 射线衍射仪对 CPC 和姜黄素磷脂复合物- Soluplus 固化粉末(CSP)的结构进行了表征,并考察了其流动性、体外溶出度和口服生物利用度。

主要发现

所有分析均表明,固化粉末中姜黄素完全从结晶态转变为无定形态。流动性研究中计算的休止角表明,从“无法测量”显著改善至“37°”。同时,溶出度研究表明,在磷酸盐缓冲条件下,CSP 在 pH6.8 时的释放度为 76.34%,在 pH1.2 时的释放度为 78.19%。此外,在药代动力学研究中,CPC 和 CSP 组的 AUC 值有显著(P<0.01)改善,结果表明 AUC 值从 205.84±50.46μg·h/ml 增加到 330.47μg·h/ml。

结论

本研究采用了一种简单方便的固化工艺,数据表明,该工艺不仅可以提高磷脂复合物的流动性和溶出度,还可以提高姜黄素的口服生物利用度。

相似文献

1
Studies on the curcumin phospholipid complex solidified with Soluplus.姜黄素磷脂复合物与 Soluplus 固化的研究。
J Pharm Pharmacol. 2018 Feb;70(2):242-249. doi: 10.1111/jphp.12857. Epub 2017 Nov 17.
2
Application of Soluplus to Improve the Flowability and Dissolution of Baicalein Phospholipid Complex.应用Soluplus改善黄芩苷磷脂复合物的流动性和溶出度。
Molecules. 2017 May 11;22(5):776. doi: 10.3390/molecules22050776.
3
Increased dissolution and oral absorption of itraconazole/Soluplus extrudate compared with itraconazole nanosuspension.与伊曲康唑纳米混悬剂相比,伊曲康唑/Soluplus 挤出物的溶解和口服吸收增加。
Eur J Pharm Biopharm. 2013 Nov;85(3 Pt B):1285-92. doi: 10.1016/j.ejpb.2013.03.002. Epub 2013 Apr 3.
4
[Solidification of magnolol phospholipid complex with polyvingypyrrolidone].厚朴酚磷脂复合物与聚乙烯吡咯烷酮的固化
Zhongguo Zhong Yao Za Zhi. 2016 Jun;41(12):2250-2254. doi: 10.4268/cjcmm20161213.
5
Enhancing solubility and bioavailability of coenzyme Q formulation of solid dispersions using Soluplus as a carrier.使用 Soluplus 作为载体提高固体分散体中辅酶 Q 制剂的溶解度和生物利用度。
Arch Pharm Res. 2022 Jan;45(1):29-37. doi: 10.1007/s12272-022-01368-4. Epub 2022 Feb 7.
6
Preparation and evaluation of curcumin-loaded self-assembled micelles.载姜黄素自组装胶束的制备及评价。
Drug Dev Ind Pharm. 2018 Apr;44(4):563-569. doi: 10.1080/03639045.2017.1405431. Epub 2017 Nov 29.
7
Enhancement of Oral Bioavailability of Curcumin by a Novel Solid Dispersion System.一种新型固体分散体系统提高姜黄素的口服生物利用度
AAPS PharmSciTech. 2015 Dec;16(6):1327-34. doi: 10.1208/s12249-014-0254-0. Epub 2015 Mar 25.
8
Solid dispersion of berberine-phospholipid complex/TPGS 1000/SiO₂: preparation, characterization and in vivo studies.盐酸小檗碱-磷脂复合物/TPGS1000/SiO₂ 固体分散体的制备、表征及体内研究。
Int J Pharm. 2014 Apr 25;465(1-2):306-16. doi: 10.1016/j.ijpharm.2014.01.023. Epub 2014 Jan 20.
9
Preparation of curcumin-hydroxypropyl-β-cyclodextrin inclusion complex by cosolvency-lyophilization procedure to enhance oral bioavailability of the drug.共溶剂-冻干法制备姜黄素-羟丙基-β-环糊精包合物以提高药物的口服生物利用度。
Drug Dev Ind Pharm. 2018 Dec;44(12):1966-1974. doi: 10.1080/03639045.2018.1505904. Epub 2018 Sep 17.
10
Third-generation solid dispersion combining Soluplus and poloxamer 407 enhances the oral bioavailability of resveratrol.第三代固体分散体结合了 Soluplus 和泊洛沙姆 407,可提高白藜芦醇的口服生物利用度。
Int J Pharm. 2021 Feb 15;595:120245. doi: 10.1016/j.ijpharm.2021.120245. Epub 2021 Jan 21.

引用本文的文献

1
Curcumin, an active component of turmeric: biological activities, nutritional aspects, immunological, bioavailability, and human health benefits - a comprehensive review.姜黄素,姜黄的一种活性成分:生物学活性、营养特性、免疫学、生物利用度及对人类健康的益处——综述
Front Immunol. 2025 Aug 21;16:1603018. doi: 10.3389/fimmu.2025.1603018. eCollection 2025.
2
Mechanism of Curcumin in the Treatment of Intrauterine Adhesions Based on Network Pharmacology, Molecular docking, and Experimental Validation.基于网络药理学、分子对接和实验验证的姜黄素治疗宫腔粘连的机制
Biochem Genet. 2025 Feb 13. doi: 10.1007/s10528-025-11049-8.
3
Clinical Trial Findings and Drug Development Challenges for Curcumin in Infectious Disease Prevention and Treatment.
姜黄素在传染病预防和治疗中的临床试验结果及药物开发挑战
Life (Basel). 2024 Sep 9;14(9):1138. doi: 10.3390/life14091138.
4
Comparative Study of Preparation, Evaluation, and Pharmacokinetics in Beagle Dogs of Curcumin β-Cyclodextrin Inclusion Complex, Curcumin Solid Dispersion, and Curcumin Phospholipid Complex.姜黄素β-环糊精包合物、姜黄素固体分散体和姜黄素磷脂复合物的制备、评价及在比格犬体内药代动力学比较研究。
Molecules. 2022 May 7;27(9):2998. doi: 10.3390/molecules27092998.
5
Curcumin: Biological Activities and Modern Pharmaceutical Forms.姜黄素:生物活性与现代药物剂型。
Antibiotics (Basel). 2022 Jan 20;11(2):135. doi: 10.3390/antibiotics11020135.
6
Antitumoral Activities of Curcumin and Recent Advances to ImProve Its Oral Bioavailability.姜黄素的抗肿瘤活性及提高其口服生物利用度的最新进展
Biomedicines. 2021 Oct 14;9(10):1476. doi: 10.3390/biomedicines9101476.
7
Combination of Phospholipid Complex and Matrix Dispersion.磷脂复合物与基质分散体的联合应用。
AAPS PharmSciTech. 2021 Jun 22;22(5):189. doi: 10.1208/s12249-021-02067-x.
8
Curcumin micelles entrapped in eudragit S-100 matrix: a synergistic strategy for enhanced oral delivery.包裹于尤特奇S-100基质中的姜黄素胶束:一种增强口服给药的协同策略。
Future Sci OA. 2021 Jan 18;7(4):FSO677. doi: 10.2144/fsoa-2020-0131.
9
Enhanced water solubility, antioxidant activity, and oral absorption of hesperetin by D-α-tocopheryl polyethylene glycol 1000 succinate and phosphatidylcholine.D-α-生育酚聚乙二醇 1000 琥珀酸酯和磷脂酰胆碱对橙皮苷水溶性、抗氧化活性和口服吸收的增强作用。
J Zhejiang Univ Sci B. 2019;20(3):273-281. doi: 10.1631/jzus.B1800346.
10
Curcumin-loaded self-nanomicellizing solid dispersion system: part I: development, optimization, characterization, and oral bioavailability.姜黄素自微乳载药固体分散体系统:第一部分:研制、优化、特性鉴定及口服生物利用度。
Drug Deliv Transl Res. 2018 Oct;8(5):1389-1405. doi: 10.1007/s13346-018-0543-3.